4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001415889-24-016427
CEO & CHIEF SCIENTIFIC OFFICER acquired 100,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zhang Jack Y. CEO & CHIEF SCIENTIFIC OFFICER | 2024-06-10 | Option exercise | +100,000 | $14.69 | $1,469,000 | 2,533,554 | D |
| Derivatives | |||||||
| Zhang Jack Y. CEO & CHIEF SCIENTIFIC OFFICER | 2024-06-10 | Option exercise · Employee Stock Option (right to buy) | −100,000 | 390,477 | D | ||
Loading xslF345X05/form4-06112024_100612.xml…